Caloric excess or restriction mediated modulation of metabolic enzyme acetylation-proposed effects on cardiac growth and function

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 7, 2011, Pages 1279-1285

  Sack, Michael N ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Acetyl CoA; Acetyltransferase; Cardiac contraction; Cardiac hypertrophy; NAD+; Sirtuins

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ACETYLATION; CALORIC RESTRICTION; DEACETYLATION; ENERGY; HEART DEVELOPMENT; HEART FUNCTION; HEART METASTASIS; HUMAN; MECHANICAL STRESS; METABOLIC REGULATION; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; REVIEW;

ACETYLATION; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CALORIC RESTRICTION; CIRCADIAN RHYTHM; ENERGY INTAKE; ENERGY METABOLISM; HEART; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIA, HEART; MYOCARDIUM; NAD; SIRTUINS;

EID: 79957965071     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.01.032     Document Type: Review

References (100)

1. S. Capewell, E.S. Ford, J.B. Croft, J.A. Critchley, K.J. Greenlund, D.R. Labarthe, Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America, Bull. World Health Organ, 88 120-130.
2. Rider O.J., Francis J.M., Ali M.K., Byrne J., Clarke K., Neubauer S., Petersen S.E. Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study. J. Cardiovasc. Magn. Reson. 2009, 11:9.
3. O.J. Rider, S.E. Petersen, J.M. Francis, M.K. Ali, L.E. Hudsmith, M.R. Robinson, K. Clarke, S. Neubauer, Ventricular hypertrophy and cavity dilatation in relation to body mass index in females with uncomplicated obesity, Heart.
4. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., Kannel W.B., Vasan R.S. Obesity and the risk of heart failure. N. Engl. J. Med. 2002, 347:305-313.
5. Kim A.S., Miller E.J., Young L.H. AMP-activated protein kinase: a core signalling pathway in the heart. Acta Physiol. (Oxf) 2009, 196:37-53.
6. Wende A.R., Abel E.D. Lipotoxicity in the heart. Biochim. Biophys. Acta 2010, 1801:311-319.
7. Brindley D.N., Kok B.P., Kienesberger P.C., Lehner R., Dyck J.R. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E897-E908.
8. Smit A.J., Hartog J.W., Voors A.A., van Veldhuisen D.J. Advanced glycation endproducts in chronic heart failure. Ann. N. Y. Acad. Sci. 2008, 1126:225-230.
9. Sack M.N. Type 2 diabetes, mitochondrial biology and the heart. J. Mol. Cell. Cardiol. 2009, 46:842-849.
10. Pagel-Langenickel I., Bao J., Pang L., Sack M.N. The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr. Rev. 2010, 31:25-51.
11. Desai A., Fang J.C. Heart failure with preserved ejection fraction: hypertension, diabetes, obesity/sleep apnea, and hypertrophic and infiltrative cardiomyopathy. Heart Fail. Clin. 2008, 4:87-97.
12. Goldrick R.B., Hirsch J. Serial studies on the metabolism of human adipose tissue. II. Effects of caloric restriction and refeeding on lipogenesis, and the uptake and release of free fatty acids in obese and nonobese individuals. J. Clin. Invest. 1964, 43:1793-1804.
13. van der Meer R.W., Hammer S., Smit J.W., Frolich M., Bax J.J., Diamant M., Rijzewijk L.J., de R.A., Romijn J.A., Lamb H.J. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 2007, 56:2849-2853.
14. Hammer S., van der Meer R.W., Lamb H.J., Schar M., de R.A., Smit J.W., Romijn J.A. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J. Clin. Endocrinol. Metab. 2008, 93:497-503.
15. Fontana L., Meyer T.E., Klein S., Holloszy J.O. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl Acad. Sci. USA 2004, 101:6659-6663.
16. Hammer S., Snel M., Lamb H.J., Jazet I.M., van der Meer R.W., Pijl H., Meinders E.A., Romijn J.A., de R.A., Smit J.W. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J. Am. Coll. Cardiol. 2008, 52:1006-1012.
17. Meyer T.E., Kovacs S.J., Ehsani A.A., Klein S., Holloszy J.O., Fontana L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J. Am. Coll. Cardiol. 2006, 47:398-402.
18. van der Meer R.W., Rijzewijk L.J., Diamant M., Hammer S., Schar M., Bax J.J., Smit J.W., Romijn J.A., de R.A., Lamb H.J. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur. Heart J. 2008, 29:1516-1522.
19. Durgan D.J., Young M.E. The cardiomyocyte circadian clock: emerging roles in health and disease. Circ. Res. 2010, 106:647-658.
20. Young M.E., Razeghi P., Taegtmeyer H. Clock genes in the heart: characterization and attenuation with hypertrophy. Circ. Res. 2001, 88:1142-1150.
21. Christoffersen C., Bollano E., Lindegaard M.L., Bartels E.D., Goetze J.P., Andersen C.B., Nielsen L.B. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003, 144:3483-3490.
22. Boudina S., Sena S., O'Neill B.T., Tathireddy P., Young M.E., Abel E.D. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005, 112:2686-2695.
23. Boudina S., Sena S., Theobald H., Sheng X., Wright J.J., Hu X.X., Aziz S., Johnson J.I., Bugger H., Zaha V.G., Abel E.D. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007, 56:2457-2466.
24. How O.J., Aasum E., Severson D.L., Chan W.Y., Essop M.F., Larsen T.S. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 2006, 55:466-473.
25. Yue P., Arai T., Terashima M., Sheikh A.Y., Cao F., Charo D., Hoyt G., Robbins R.C., Ashley E.A., Wu J., Yang P.C., Tsao P.S. Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H2106-H2118.
26. Belke D.D., Larsen T.S., Gibbs E.M., Severson D.L. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E1104-E1113.
27. Semeniuk L.M., Kryski A.J., Severson D.L. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H976-H982.
28. Mizushige K., Yao L., Noma T., Kiyomoto H., Yu Y., Hosomi N., Ohmori K., Matsuo H. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 2000, 101:899-907.
29. Sharma N., Okere I.C., Barrows B.R., Lei B., Duda M.K., Yuan C.L., Previs S.F., Sharov V.G., Azimzadeh A.M., Ernsberger P., Hoit B.D., Sabbah H., Stanley W.C. High-sugar diets increase cardiac dysfunction and mortality in hypertension compared to low-carbohydrate or high-starch diets. J. Hypertens. 2008, 26:1402-1410.
30. Ouwens D.M., Diamant M., Fodor M., Habets D.D., Pelsers M.M., El H.M., Dang Z.C., van den Brom C.E., Vlasblom R., Rietdijk A., Boer C., Coort S.L., Glatz J.F., Luiken J.J. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 2007, 50:1938-1948.
31. Burgmaier M., Sen S., Philip F., Wilson C.R., Miller C.C., Young M.E., Taegtmeyer H. Metabolic adaptation follows contractile dysfunction in the heart of obese Zucker rats fed a high-fat "Western" diet. Obesity (Silver. Spring) 2010.
32. McGavock J.M., Lingvay I., Zib I., Tillery T., Salas N., Unger R., Levine B.D., Raskin P., Victor R.G., Szczepaniak L.S. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007, 116:1170-1175.
33. Scheuermann-Freestone M., Madsen P.L., Manners D., Blamire A.M., Buckingham R.E., Styles P., Radda G.K., Neubauer S., Clarke K. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003, 107:3040-3046.
34. de las F.L., Waggoner A.D., Mohammed B.S., Stein R.I., Miller B.V., Foster G.D., Wyatt H.R., Klein S., Davila-Roman V.G. Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J. Am. Coll. Cardiol. 2009, 54:2376-2381.
35. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L., Zeng Y., Li H., Li Y., Shi J., An W., Hancock S.M., He F., Qin L., Chin J., Yang P., Chen X., Lei Q., Xiong Y., Guan K.L. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.
36. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., Zhao Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23:607-618.
37. Lin Y.Y., Lu J.Y., Zhang J., Walter W., Dang W., Wan J., Tao S.C., Qian J., Zhao Y., Boeke J.D., Berger S.L., Zhu H. Protein acetylation microarray reveals that NuA4 controls key metabolic target regulating gluconeogenesis. Cell 2009, 136:1073-1084.
38. Lu Z., Scott I., Webster B.R., Sack M.N. The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology. Circ. Res. 2009, 105:830-841.
39. Finkel T., Deng C.X., Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460:587-591.
40. Blander G., Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 2004, 73:417-435.
41. Guarente L. Mitochondria-a nexus for aging, calorie restriction, and sirtuins?. Cell 2008, 132:171-176.
42. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 2000, 273:793-798.
43. Haigis M.C., Guarente L.P. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006, 20:2913-2921.
44. Nakagawa T., Lomb D.J., Haigis M.C., Guarente L. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009, 137:560-570.
45. Schwer B., Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab. 2008, 7:104-112.
46. Shi T., Wang F., Stieren E., Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 2005, 280:13560-13567.
47. Tanno M., Sakamoto J., Miura T., Shimamoto K., Horio Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 2007, 282:6823-6832.
48. Schwer B., North B.J., Frye R.A., Ott M., Verdin E. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J. Cell Biol. 2002, 158:647-657.
49. Onyango P., Celic I., McCaffery J.M., Boeke J.D., Feinberg A.P. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl Acad. Sci. USA 2002, 99:13653-13658.
50. Lombard D.B., Alt F.W., Cheng H.L., Bunkenborg J., Streeper R.S., Mostoslavsky R., Kim J., Yancopoulos G., Valenzuela D., Murphy A., Yang Y., Chen Y., Hirschey M.D., Bronson R.T., Haigis M., Guarente L.P., Farese R.V., Weissman S., Verdin E., Schwer B. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 2007, 27:8807-8814.
51. Cooper H.M., Spelbrink J.N. The human SIRT3 protein deacetylase is exclusively mitochondrial. Biochem. J. 2008, 411:279-285.
52. Sundaresan N.R., Samant S.A., Pillai V.B., Rajamohan S.B., Gupta M.P. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol. Cell. Biol. 2008, 28:6384-6401.
53. Nakamura Y., Ogura M., Tanaka D., Inagaki N. Localization of mouse mitochondrial SIRT proteins: shift of SIRT3 to nucleus by co-expression with SIRT5. Biochem. Biophys. Res. Commun. 2008, 366:174-179.
54. Scher M.B., Vaquero A., Reinberg D. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev. 2007, 21:920-928.
55. Bao J., Lu Z., Joseph J.J., Carabenciov D., Dimond C.C., Pang L., Samsel L., McCoy J.P., Leclerc J., Nguyen P., Gius D., Sack M.N. Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms. J. Cell. Biochem. 2010, 110:238-247.
56. Schlicker C., Gertz M., Papatheodorou P., Kachholz B., Becker C.F., Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 2008, 382:790-801.
57. Lin S.J., Defossez P.A., Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000, 289:2126-2128.
58. Anderson R.M., Bitterman K.J., Wood J.G., Medvedik O., Cohen H., Lin S.S., Manchester J.K., Gordon J.I., Sinclair D.A. Manipulation of a nuclear NAD+salvage pathway delays aging without altering steady-state NAD+levels. J. Biol. Chem. 2002, 277:18881-18890.
59. Dioum E.M., Chen R., Alexander M.S., Zhang Q., Hogg R.T., Gerard R.D., Garcia J.A. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 2009, 324:1289-1293.
60. Tong L., Denu J.M. Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose. Biochim. Biophys. Acta 2010.
61. Bitterman K.J., Anderson R.M., Cohen H.Y., Latorre-Esteves M., Sinclair D.A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 2002, 277:45099-45107.
62. Ito Y., Yonekura R., Maruta K., Koike T., Nakagami Y., Shibata K., Saito K., Nagamura Y. Tryptophan metabolism was accelerated by exercise in rat. Adv. Exp. Med. Biol. 2003, 527:531-535.
63. Revollo J.R., Grimm A.A., Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 2004, 279:50754-50763.
64. Berger F., Lau C., Dahlmann M., Ziegler M. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J. Biol. Chem. 2005, 280:36334-36341.
65. Yang H., Yang T., Baur J.A., Perez E., Matsui T., Carmona J.J., Lamming D.W., Souza-Pinto N.C., Bohr V.A., Rosenzweig A., de C.R., Sauve A.A., Sinclair D.A. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 2007, 130:1095-1107.
66. Hsu C.P., Hariharan N., Alcendor R.R., Oka S., Sadoshima J. Nicotinamide phosphoribosyltransferase regulates cell survival through autophagy in cardiomyocytes. Autophagy 2009, 5:1229-1231.
67. Pillai V.B., Sundaresan N.R., Kim G., Gupta M., Rajamohan S.B., Pillai J.B., Samant S., Ravindra P.V., Isbatan A., Gupta M.P. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMPK pathway. J. Biol. Chem. 2009.
68. Sack M.N., Rader T.A., Park S., Bastin J., McCune S.A., Kelly D.P. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996, 94:2837-2842.
69. Sack M.N., Kelly D.P. The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review). Int. J. Mol. Med. 1998, 1:17-24.
70. Okere I.C., Young M.E., McElfresh T.A., Chess D.J., Sharov V.G., Sabbah H.N., Hoit B.D., Ernsberger P., Chandler M.P., Stanley W.C. Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension 2006, 48:1116-1123.
71. J.M. Berthiaume, M.S. Bray, T.A. McElfresh, X. Chen, S.M. Azam, M.E. Young, B.D. Hoit, M.P. Chandler, Myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure, Am. J. Physiol Heart Circ. Physiol.
72. Chess D.J., Khairallah R.J., O'Shea K.M., Xu W., Stanley W.C. A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1585-H1593.
73. Gerhart-Hines Z., Rodgers J.T., Bare O., Lerin C., Kim S.H., Mostoslavsky R., Alt F.W., Wu Z., Puigserver P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 2007, 26:1913-1923.
74. Canto C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., Elliott P.J., Puigserver P., Auwerx J. AMPK regulates energy expenditure by modulating NAD+metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
75. Hou X., Xu S., Maitland-Toolan K.A., Sato K., Jiang B., Ido Y., Lan F., Walsh K., Wierzbicki M., Verbeuren T.J., Cohen R.A., Zang M. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 2008, 283:20015-20026.
76. Lan F., Cacicedo J.M., Ruderman N., Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 2008, 283:27628-27635.
77. Pagel-Langenickel I., Bao J., Joseph J.J., Schwartz D.R., Mantell B.S., Xu X., Raghavachari N., Sack M.N. PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle. J. Biol. Chem. 2008, 283:22464-22472.
78. Alcendor R.R., Kirshenbaum L.A., Imai S., Vatner S.F., Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ. Res. 2004, 95:971-980.
79. Alcendor R.R., Gao S., Zhai P., Zablocki D., Holle E., Yu X., Tian B., Wagner T., Vatner S.F., Sadoshima J. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 2007, 100:1512-1521.
80. Hirschey M.D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D.B., Grueter C.A., Harris C., Biddinger S., Ilkayeva O.R., Stevens R.D., Li Y., Saha A.K., Ruderman N.B., Bain J.R., Newgard C.B., Farese R.V., Alt F.W., Kahn C.R., Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125.
81. Sundaresan N.R., Gupta M., Kim G., Rajamohan S.B., Isbatan A., Gupta M.P. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 2009, 119:2758-2771.
82. Hallows W.C., Lee S., Denu J.M. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl Acad. Sci. USA 2006, 103:10230-10235.
83. Schwer B., Bunkenborg J., Verdin R.O., Andersen J.S., Verdin E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl Acad. Sci. USA 2006, 103:10224-10229.
84. Shimazu T., Hirschey M.D., Hua L., Dittenhafer-Reed K.E., Schwer B., Lombard D.B., Li Y., Bunkenborg J., Alt F.W., Denu J.M., Jacobson M.P., Verdin E. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 2010, 12:654-661.
85. Ahn B.H., Kim H.S., Song S., Lee I.H., Liu J., Vassilopoulos A., Deng C.X., Finkel T. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl Acad. Sci. USA 2008, 105:14447-14452.
86. Cimen H., Han M.J., Yang Y., Tong Q., Koc H., Koc E.C. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 2010, 49:304-311.
87. Law I.K., Liu L., Xu A., Lam K.S., Vanhoutte P.M., Che C.M., Leung P.T., Wang Y. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Proteomics 2009, 9:2444-2456.
88. Bao J., Scott I., Lu Z., Pang L., Dimond C.C., Gius D., Sack M.N. SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic. Biol. Med. 2010, 49:1230-1237.
89. Qiu X., Brown K., Hirschey M.D., Verdin E., Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010, 12:662-667.
90. Someya S., Yu W., Hallows W.C., Xu J., Vann J.M., Leeuwenburgh C., Tanokura M., Denu J.M., Prolla T.A. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010, 143:802-812.
91. Wang F., Nguyen M., Qin F.X., Tong Q. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 2007, 6:505-514.
92. Lynn E.G., McLeod C.J., Gordon J.P., Bao J., Sack M.N. SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells. FEBS Lett. 2008, 582:2857-2862.
93. Vakhrusheva O., Smolka C., Gajawada P., Kostin S., Boettger T., Kubin T., Braun T., Bober E. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ. Res. 2008, 102:703-710.
94. Ladurner A.G. Chromatin places metabolism center stage. Cell 2009, 138:18-20.
95. Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009, 324:1076-1080.
96. Kelly T.J., Lerin C., Haas W., Gygi S.P., Puigserver P. GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation. J. Biol. Chem. 2009.
97. Nemoto S., Fergusson M.M., Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J. Biol. Chem. 2005, 280:16456-16460.
98. Kelly D.P., Scarpulla R.C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004, 18:357-368.
99. McLeod C.J., Pagel I., Sack M.N. The mitochondrial biogenesis regulatory program in cardiac adaptation to ischemia-a putative target for therapeutic intervention. Trends Cardiovasc. Med. 2005, 15:118-123.
100. Horie S., Isobe M., Suga T. Changes in CoA pools in hepatic peroxisomes of the rat under various conditions. J. Biochem. 1986, 99:1345-1352.